SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-011997
Filing Date
2022-02-04
Accepted
2022-02-04 16:31:22
Documents
1
Group Members
LUNG BIOTECHNOLOGY PBC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tm225301d1_sc13g.htm SC 13G 62630
  Complete submission text file 0001104659-22-011997.txt   64284
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filed by) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 170 PARK AVENUE FLORHAM PARK NJ 07932
Business Address 170 PARK AVENUE FLORHAM PARK NJ 07932 908-845-4366
Celularity Operations Inc. (Subject) CIK: 0001716918 (see all company filings)

IRS No.: 813931841 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93335 | Film No.: 22593933